LinkedIn · Jul 2026
Company announcement introducing Invert University, a community/science initiative for sharing bioprocess research and highlighting ongoing customer engagement.
Data analytics software for biomanufacturing.
Public company, workplace, funding, and market signals
Updated Jul 29, 2026
Invert is a bioprocess infrastructure and intelligence company that connects equipment and data sources across upstream and downstream workflows so biopharma, synthetic biology, and CDMO teams can unify, analyze, and act on process data faster.
Primary product
Bioprocess data infrastructure and AI analysis platform (Invert Assist)
Founded
2021
Headquarters
San Francisco, California, United States
Team size
11-50 employees
Work style
Remote
Industry
Biotechnology Research
Sub-industry
Bioprocess AI software
Offices
6 jobs at Invert
Business model
Stage
Series A
Total raised
$20.7M
Latest round
Series A1 · Jun 2024
Latest amount
$20.1M
Jun 2024 · Giant Ventures
Mar 2022
Jan 2022
Dec 2021
Leadership
Co-Founder & CEO
Co-Founder & CTO
Chief of Staff & Head of Operations
Head of Talent Management
Head of Customer Experience
Head of SRE
Head of Marketing
Director of Strategic Accounts
Head of Product
Software Engineering Manager
Emily Nault
Senior Vice President of Commercial
Mission-driven, high-ownership, builder-oriented culture with four explicit operating archetypes: Builders, Accelerators, Operators, and Connectors. The company emphasizes autonomy, customer connection, and shipping in a hard, regulated domain.
Work style
Remote
Compensation
Public careers materials advertise competitive salary plus equity, unlimited PTO, parental leave, team offsites, retirement matching, home-office stipends, and full health/dental/vision coverage. Public compensation bands are not disclosed.
Benefits
Pricing
Public pricing is not disclosed; sales appear demo-led and enterprise-oriented.
Differentiators
Technology
Customers
Competitors
Estimated revenue
≈US$5M ARR (public estimate)
Estimated monthly visits
11.3K
Traffic estimate as of Apr 2026
LinkedIn · Jul 2026
Company announcement introducing Invert University, a community/science initiative for sharing bioprocess research and highlighting ongoing customer engagement.
Invert blog · Nov 2025
Technical post on the company’s security and compliance approach, including risk-based development, auditability, and AI governance.
Invert blog · Nov 2025
Explains Invert’s real-time time-series handling, lineage across unit operations, and alerting for regulated bioprocess workflows.
Invert blog · Nov 2025
Webinar recap explaining how Invert Assist layers explainable AI on top of Invert’s harmonized data foundation to accelerate scale-up and quality control.
PR Newswire · Oct 2025
Official launch announcement for Invert Assist, the company’s AI-powered bioprocess analysis interface. It emphasizes natural-language analysis, reproducible Python, and regulated-manufacturing compliance.